Large knee market Target the $5B knee treatment market as the primary entry point for KneeStim, emphasizing mobility and remote rehabilitation to appeal to surgeons, clinics, and payers seeking cost- and time-efficient conservative options.

Clinical validation Leverage independent market validation and feasibility studies, plus the regulatory pathway and identified reimbursement codes, to accelerate conversations with clinical decision-makers and procurement teams about adoption prerequisites.

Prototype readiness With a working prototype and NMES-based KneeStim, pursue pilots with orthopedic practices, physical therapy networks, and rehabilitation clinics to demonstrate real-world efficacy and gather payer-ready data.

IP and partnerships Highlight four issued patents and existing partnerships (e.g., Fahrenheit Design) to support competitive differentiation, potential licensing talks, and co-development opportunities with device manufacturers or clinical distributors.

Awards and visibility Capitalize on industry awards and media attention to open introductions with strategic investors, healthcare distributors, and hospital systems seeking innovative wearables for remote rehabilitation and outpatient care.